• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Cell Analysis Market 2017- Forecast to 2023 for the $47.08 Billion Market - Research and Markets

    Global Cell Analysis Market 2017- Forecast to 2023 for the $47.08 Billion Market - Research and Markets

  2. Evotec and Eternygen to Develop Novel Metabolic Disease Therapy

    Evotec and Eternygen to Develop Novel Metabolic Disease Therapy

  3. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  4. Eurofins Reinforces Its Footprint in Discovery Pharmacology with the Acquisition of Villapharma in Spain

    Eurofins Reinforces Its Footprint in Discovery Pharmacology with the Acquisition of Villapharma in Spain

  5. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  6. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-cap international stocks.

  7. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.